Blueprint Medicines Wins Big in Early-Stage Trial
Blueprint Medicines watched its shares make a solid gain on Monday morning after the firm announced results for its ongoing early-stage trial for advanced systemic mastocytosis.
All Work
Chris Lange
Costco, Oracle and More Earnings Coming This Week
24/7 Wall St. has put together a preview of Adobe, Costco, Oracle and some of the other top companies reporting their latest results in the coming week.
More Alliances and Betrayals in the Online Streaming Wars
Apple and Amazon.com have announced a groundbreaking partnership that will put the Amazon Prime streaming service on Apple TV. This is the most recent move in the online streaming wars.
Denali Therapeutics Enters the Market With a Bang
Denali Therapeutics entered the markets with a bang on Friday. In its initial public offering, the company priced its almost 14 million shares within the expected range.
Radius Health Breast Cancer Trial Continues to Show Progress
Radius Health shares climbed higher on Friday after the firm provided an update on its early-stage clinical study in patients with estrogen receptor positive breast cancer.
Is This the Turnaround SteadyMed Has Waited For?
SteadyMed saw its shares make an incredibly gain to close out the week, after a positive meeting with the FDA.
Will Alexion Pharmaceuticals Fight This Activist?
Alexion Pharmaceuticals shares saw a handy gain early on Friday after the New York Times reported that there might be some increasing activist movement in the stock.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a solid day for the broad U.S. markets. The Dow, S&P 500 and Nasdaq all recovered from their losses earlier this week, although not entirely. Crude oil made a small comeback after…
How Dollar General Earnings Are Pushing the Stock to New Highs
After Dollar General reported better-than-expected fiscal third-quarter financial results, its shares briefly hit a 52-week high -- almost an all-time high.
Could Sage Therapeutics’ Depression Drug Be the Next Big Thing?
Sage Therapeutics saw its shares make an incredible gain on Thursday after the firm announced positive top-line results from its midstage trial.
Economic Outlook Might Be Brighter Than Ever According to Executives
Roughly three out of four business executives have an optimistic view of the U.S. economy over the next 12 months, according to a new survey.
Anheuser-Busch Goes for the Green With New Tesla Deal
Tesla has been pushing the envelope for batteries and autonomous vehicles, and the firm just found its newest client in Anheuser-Busch InBev.
Things Are Looking Up for Broadcom
Shares of Broadcom rose early Thursday after it released its most recent quarterly results late on Wednesday.
Why Lululemon Earnings Are Zen
Shares of Lululemon Athletica jumped after it reported its most recent quarterly results late on Wednesday.
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday was a mixed day for the broad U.S. markets. All three indices shifted from positive to negative multiple times throughout the session. The Dow is still holding above 24,000 but it has backed…
6 Stocks Seeing Multiple Analysts Raise Their Price Targets
24/7 Wall St. has taken a look at some of the biggest analyst calls on Wednesday that are driving stocks and we have included some of the biggest analyst highlights.
CURO Group Closes in on IPO
Consumer finance company CURO expects to price more than 6 million shares in the range that results in an initial public offering valued up to more than $122 million.
Arrowhead Pharma Wins in Midstage Hepatitis Study
Arrowhead Pharmaceuticals saw its shares make a handy gain on Wednesday after the firm presented new data from its midstage study for the treatment of hepatitis B infection.
Amazon and Apple Join Forces in Online Streaming Wars
The online streaming wars are heating up, and the story might be as good as the content on some of these services.
American Eagle Missed Earnings Outweighed by Guidance
American Eagle Outfitters reported disappointing fiscal third-quarter financial results before the markets opened on Wednesday.